PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 6,070.00
+180.00 (3.06%)
At close: Dec 5, 2025
PanGen Biotech Revenue
PanGen Biotech had revenue of 4.01B KRW in the quarter ending September 30, 2025, a decrease of -12.67%. This brings the company's revenue in the last twelve months to 15.27B, up 11.30% year-over-year. In the year 2024, PanGen Biotech had annual revenue of 14.67B with 100.58% growth.
Revenue (ttm)
15.27B
Revenue Growth
+11.30%
P/S Ratio
5.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
81.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.67B | 7.36B | 100.58% |
| Dec 31, 2023 | 7.32B | 814.47M | 12.53% |
| Dec 31, 2022 | 6.50B | -1.43B | -18.08% |
| Dec 31, 2021 | 7.94B | 1.74B | 28.18% |
| Dec 31, 2020 | 6.19B | 3.31B | 114.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |